Stockreport

CG Oncology Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]

CG Oncology, Inc.  (CGON) 
PDF Revenue missed analyst estimates by 79%. Earnings per share (EPS) exceeded analyst estimates by 21%. Looking ahead, revenue is forecast to grow 70% p.a. on average du [Read more]